Annual report pursuant to Section 13 and 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.24.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2020
Nov. 30, 2023
Jan. 31, 2022
Related Party Transaction [Line Items]                
Research and development related expenses       $ 1,159,993 $ 1,022,412      
Compensation expense         30,000      
Accrued director fees $ 8,625     8,625 101,991   $ 82,133 $ 87,083
Directors fees paid previously accrued 169,216     169,216        
Proceeds from issuance of common stock       1,164,246 1,402,500      
Common Stock [Member]                
Related Party Transaction [Line Items]                
Proceeds from issuance of common stock     $ 1,144,501 30 31      
Private Placement [Member]                
Related Party Transaction [Line Items]                
Proceeds from issuance of common stock 250,000 $ 600,000            
Private Placement [Member] | Common Stock [Member]                
Related Party Transaction [Line Items]                
Proceeds from issuance of common stock 600,000              
Audit Committee [Member]                
Related Party Transaction [Line Items]                
Annual fees       7,500 20,000      
Compensation Committee [Member]                
Related Party Transaction [Line Items]                
Annual fees       5,000 15,000      
Nominating And Governance Committee [Member]                
Related Party Transaction [Line Items]                
Annual fees       3,500        
IGL Pharma, Inc. [Member]                
Related Party Transaction [Line Items]                
Research and development related expenses       0 105,382      
Related Party [Member] | Service [Member]                
Related Party Transaction [Line Items]                
Due to related party 1,321     1,321 13,900      
Officers and Directors [Member]                
Related Party Transaction [Line Items]                
Proceeds from short-term notes payable           $ 45,500    
Bearing interest           10.00%    
Short-term notes payable outstanding 7,500     7,500 7,500      
Nominating And Governance Committee [Member]                
Related Party Transaction [Line Items]                
Annual fees         $ 10,000      
Chairman [Member]                
Related Party Transaction [Line Items]                
Investors $ 100,000     $ 100,000        
IGL Pharma, Inc. [Member] | President [Member]                
Related Party Transaction [Line Items]                
Non-controlling equity interest 1.00%     1.00%        
Annual fees       $ 500